# Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit

Source: https://onco.cc/key-papers/paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023/  
OnCo record `paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Of 124 indications of cancer medicines authorised in the EU from 2011 to 2020, Hungary reimbursed 40%, and the median wait from authorisation to reimbursement was 37 months, the longest of the four countries studied.

## Summary

The authors followed 124 indications of 51 cancer medicines authorised by the European Medicines Agency in 2011 to 2020 until 2022, and compared reimbursement status and waiting time in Czechia, Hungary, Poland and Slovakia against each indication's ESMO Magnitude of Clinical Benefit Scale rating.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: ESMO Open
- Year: 2023
- DOI: 10.1016/j.esmoop.2023.101593
- Authors: Hofmarcher T, Szilagyiova P, Gustafsson A, Dolezal T, Rutkowski P, Baxter C, Karamousouli E.
- Findings: Reimbursed indications: 64% in Czechia, 40% in Hungary, 51% in Poland and 19% in Slovakia.; In every country, indications with substantial clinical benefit were more likely to be reimbursed (P < 0.05).; Median waiting time to reimbursement ranged from 27 months in Poland to 37 months in Hungary, with no difference by clinical benefit (P = 0.25 to 0.84).
- What it means: Hungarian patients waited a median of just over three years for new cancer medicines to be reimbursed, and the wait was no shorter for the medicines that help most.
- Caveats: Data end in 2022, before Hungary's 2024 inclusion of new oncology medicines in public financing.; Four countries only, and reimbursement status is counted per indication, not per patient treated.

## Sources

- ESMO Open 2023: https://doi.org/10.1016/j.esmoop.2023.101593
- PubMed: https://pubmed.ncbi.nlm.nih.gov/37413761/

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- institutions: [National Health Insurance Fund of Hungary (Nemzeti Egészségbiztosítási Alapkezelő)](https://onco.cc/institutions/neak-hungary/)

---
JSON: https://onco.cc/api/v1/entities/paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023.json